Phase 3 Study of ProstAtak™ With Standard Radiation Therapy for Localized Prostate Cancer (PrTK03)
 
Sponsors and Collaborators
Advantagene, Inc.
 
Contact

Click here and scroll down to view study contact and location info

 
ClinicalTrials.gov Identifier